Preeclampsia is a pregnancy-specific condition affecting 2-7% of women and a leading cause of perinatal and maternal morbidity and mortality. Preeclampsia may also predispose the fetus to increased risks of adult cardiovascular disease. Selenium, acting through the selenoprotein glutathione peroxidases, has critical roles in regulating antioxidant status. Recent reports implicate poor maternal selenium status as a nutritional factor predisposing the mother to preeclampsia but the fetus and placenta have not been studied in tandem. Measurement of selenium concentrations, expression and activity levels of glutathione peroxidase and markers of oxidative stress were performed on maternal and umbilical venous blood samples or the placenta from 27 normal pregnant, 25 preeclamptic and 22 healthy age-matched non-pregnant women. The results of this study revealed highly significant reductions in serum selenium concentrations and plasma glutathione peroxidase activity in pregnancy per se compared to non-pregnant controls. Moreover, these levels were further decreased in the preeclamptic mothers and babies compared to normal pregnancies. Umbilical venous selenium was particularly low (42.1±11.8 and 29.0 ± 9.9 g/L; mean ±s.d.; P<0.05). Both mother and baby had significantly increased levels of markers for oxidative stress in the preeclamptic group.
Introduction
Preeclampsia is estimated to occur in 2-7% of all pregnancies and is a leading cause of maternal and perinatal mortality and morbidity in the Western world 1 ; together with other hypertensive disorders of pregnancy it is responsible for approximately 60,000 deaths each year 2 . Moreover, the effects of the disease are not restricted to pregnancy as it also predisposes both the mother and baby to adult cardiovascular disease 3 . Preeclampsia is now commonly regarded as being a state of oxidative stress, thought to arise from a biochemical imbalance which occurs from excessive generation of free radical formation and/or inadequate antioxidant capacity (see: 4 ). It is thought that excessive production of reactive oxygen species (ROS), resulting in oxidative stress secondary to reduced placental perfusion plays a critical role as a possible mediator of endothelial cell dysfunction 5 , hypertension and thus clinical manifestations of preeclampsia 6 .
The trace element selenium is an essential component of the antioxidant selenoproteins, including glutathione peroxidases (GPx). These remove the products of attack by ROS (hydroperoxides and oxidized lipoproteins) which can break down to further reactive free radicals and cytotoxic agents 7 , and so limit adverse effects on the endothelium 8 . Various forms of GPx are found in vertebrates: the cellular and cytosolic GPx (GPx1), the cytosolic gastrointestinal GPx (GPx2), the extracellular plasma GPx (GPx3) and the phospholipid hydroperoxide GPx (GPx4) 9 . Two studies have shown decreases in maternal serum or toenail selenium concentrations in preeclamptic patients compared to normal pregnant controls 10, 11 and other studies have reported significant reductions in maternal plasma 12 and placental 13, 14 GPx activities in preeclamptic patients. We are not aware of any studies linking selenium and GPx in the mother, placenta and baby. We hypothesized that fetal selenium and GPx concentrations would also be reduced in preeclamptic pregnancy, which could contribute to present morbidity and future cardiovascular risk. We have therefore conducted a crosssectional study to explore these factors in tandem comparing patients and their babies from normal and preeclamptic pregnancies and, when appropriate, non-pregnant controls.
Methods

Power calculations:
We calculated that a sample of 25 normal pregnant and 25 preeclamptic women would give us a 95% power of detecting a 30% difference in serum selenium concentration.
Subjects:
The study population consisted of three groups of Caucasian women: 27 normal, 25 (2) RNA and polymerase provided but no RT; and (3) RNA and RT provided but no polymerase.
GPx activity assay: GPx activity was determined by a modified method of Paglia and were added to the cuvette along with 50 μl of 20 mM tert-butyl hydroperoxide, a suitable substrate for GPx. The decrease in A340 was determined over a 3-min period and rate calculations were performed. GPx activity was standardised against protein concentrations and expressed as mmol/min/mg protein or mmol/min/ml for plasma samples; the inter-and intra-assay variations were < 5%.
Histological analysis: Serial sections of 5μm were cut in the same orientation from paraffinembedded tissue blocks (Sledge Microtome, Anglia Scientific, Norwich, UK) and mounted onto Superfrost plus glass microscope slides (Menzel-Glaser, Braunschweig, Germany).
Before use, sections were dewaxed by immersion in xylene followed by rehydration in descending concentrations of alcohol (3 min each).
Immunohistochemistry: Immunohistochemical analysis was performed using the Dako Envision™ visualization system (Dako, Ely, UK). All GPx antibodies were purchased from Autogen Bioclear; Table 2 provides further details on antibody dilutions and positive controls.
Antibodies to cytokeratin (CK-7) and CD-68 (Santa Cruz Biotechnology, Calne, UK) were used to confirm positive GPx staining in cytotrophoblast and Hofbauer cells respectively (Table 2) . A negative control was performed for each test section by omitting incubation in the primary antibody. Sections were dehydrated in ascending concentrations of alcohol and xylene before coverslips were mounted (DPX mountant, BDH).
Quantification was performed at x400 magnification (Leica DM RB microscope) using a previously described method that allows counting of positively stained cells/areas and requires no corrections based on other estimated quantities 20 ; Openlab software (Improvision Openlab 4.0.2) was used for quantification. All analysis was performed blinded as to group by the same assessor using a reference slide to check for consistency. 21 using the method of Wilks was used to determine which of the markers studied allowed best discrimination between normal pregnancy and preeclampsia. The null hypothesis was rejected where P < 0.05. Table 3 describes the demographic, obstetric and pregnancy data of the 74 women who participated in the study. All pregnancy groups conceived spontaneously and carried singleton pregnancies. The normal pregnancy group gave birth without developing hypertension or proteinuria, to infants weighing > 2500 g, delivered 37 weeks or later. The systolic and diastolic blood pressure levels were, by definition, significantly raised in preeclampsia compared to normal pregnancy (P < 0.0001). Overall, the preeclamptic women all had moderate to severe disease and also had lower gestational ages at delivery than the control group (P < 0.0001) ( Table 3) . No preeclamptic woman had HELLP. All neonates from both pregnancy groups survived.
Results
Subjects:
Biochemical and molecular measurements:
The values of plasma TBARS, serum selenium concentrations and plasma GPx activities are given in Table 4 . Maternal plasma TBARS levels were significantly higher in preeclampsia compared to both normal pregnancy and nonpregnant controls (P < 0.001); no significant differences were observed between non-pregnant and normal pregnancy samples. Umbilical venous TBARS concentrations were also significantly higher in preeclamptic than normal pregnancy (P = 0.04).
There was a highly-significant trend for decreasing plasma selenium concentrations from nonpregnant, to normal pregnant and pre-eclamptic women (Table 4 ; Kendall's ; P<0.001).
Selenium concentrations were also significantly reduced in umbilical venous samples in preeclampsia by comparison with samples from babies of normotensive mothers (P < 0.0001).
There was also a highly-significant trend for decreasing plasma GPx activity from nonpregnant, to normal pregnant and pre-eclamptic women (Table 4 ; Kendall's ; P<0.001).
Umbilical venous plasma GPx activities were also significantly lower in preeclampsia than in normal pregnancy samples (P < 0.005). There was a highly-significant overall correlation between maternal serum selenium concentrations with both maternal plasma and placental
GPx activity (Figure 1a & b; r = 0.49; P < 0.001 and r = 0.38; P = 0.005 respectively), but no significant association within individual groups, or between umbilical venous serum selenium and GPx activity.
No significant differences were observed in placental mRNA expression levels of GPx1, 3
and 4 (P > 0.1) ( Table 5 ). As expected, no biologically significant placental GPx2 mRNA expression was observed. Significantly lower activity of placental GPx activity was seen in preeclampsia compared to normal pregnancy placentae (P < 0.0001) ( Table 5) . No significant differences in placental GPx activities were seen between sampling sites (P > 0.1), thus mean values are represented. A significant negative correlation was observed between placental GPx activity and maternal TBARS concentrations in preeclampsia only (Figure 2 ).
Due to the large spread of the corrected birthweight centiles in the preeclampsia group (Table   3) , we examined maternal GPx activity in mothers who gave birth to infants above and below the 50 th centiles. Univariate analysis of variance indicated that both pregnancy group and centile above/below 50 th centile significantly react with maternal GPx activities (P < 0.001, P = 0.021 respectively) ( Figure 3) . 
Discriminant function analysis:
Stepwise discriminant function analysis was applied to the whole sample using maternal serum selenium concentrations and plasma GPx activity produced a significant Wilks' lambda test (assed using the F test) 21 (Table 6 ) (P < 0.0001).
DFA using these measurements correctly predicted 82% of the subjects, with correct classification of 84.6% of normal pregnancies and 78.3% of preeclamptic patients (Table 6) .
Discussion
At present the source of the lipid peroxides in preeclampsia is unknown, but it has been suggested that poorly perfused placental tissue may evoke a free radical cascade and increase in generalised lipid peroxidation 22 . By entering the maternal circulation, these lipid peroxides could affect the maternal endothelial cellular membranes by the increased production of ROS, thus contributing to the maternal vascular dysfunction 10 . The significantly raised concentration of TBARS, a surrogate measure of lipid peroxidation, in the maternal circulation confirms previous reports 10, 12 . However, previous studies investigating oxidative stress have focussed on maternal parameters and only a single study appears to have been carried out in the fetus 23 . Our study also investigated umbilical venous concentrations of TBARS, which were significantly increased after preeclamptic pregnancy compared with normal pregnancy, indicative of increased oxidative stress. Defective placentation in preeclampsia could prevent the active placental transport of these lipid peroxides away from the fetus thus increasing the levels of TBARS in the umbilical venous samples. This prenatal exposure to raised lipid peroxidation might be one of the factors predisposing the baby of the preeclamptic mother to cardiovascular disease in later life 24, 25 .
Worryingly, the selenium concentrations in the non-pregnant women were lower than the recommended levels, as observed in other studies (eg 26 ), suggesting that the selenium concentrations may not actually be high enough for optimum GPx activities even in the nonpregnant population of the United Kingdom. The selenium concentrations are further reduced in normal pregnancies (Table 4) , illustrating a possible increased requirement for selenium during pregnancy. However, this could also be due to inadequate absorption from the gastrointestinal tract, or inadequate renal reabsorption in the face of the increased glomerular filtration rate of pregnancy. Moreover this study also observed a further significant reduction in maternal selenium concentrations in the preeclamptic samples compared to both the normal pregnant and non-pregnant controls; this is in line with other studies 10, 11 which measured serum selenium in samples with widely varying gestational ages and in toenail selenium concentrations respectively. The lower selenium concentrations seen in preeclampsia might adversely affect the functional activities of the selenoproteins, GPx, thus compromising the protection against oxidative stress. Also, a recent report linked increased selenium intake over two years with significantly decreased excretion of the major thromboxane metabolite 27 . An early imbalance between thromboxane and prostacyclin synthesis has been implicated in the pathogenesis of preeclampsia over the last 20 years (eg 28, 29 ).
The source of selenium to the fetus is via placental transport across a concentration gradient from the maternal circulation 30 . In the present study, selenium concentrations were significantly lower in the neonates of both groups, as compared to matched maternal serum; selenium is transported by simple diffusion across the placenta 31 . It is evident (Table 4 ) that the reduced selenium in the maternal circulation in preeclampsia is having a profound effect on the fetal selenium concentrations and thus could also compromise the mechanisms to protect the fetus from oxidative stress.
The lower maternal and umbilical venous GPx activities observed in the preeclamptic samples
indicates that insufficient antioxidant defence may be a contributing factor to the pathophysiological mechanisms associated with oxidative stress and preeclampsia. However, it must be remembered that measured GPx activities should only be viewed in combination with other biomarkers, as its activity in plasma, unless organ specific, can be misleading.
Nevertheless, our results provide information regarding a component of the global antioxidant defence levels in both the mother and baby. The reduced plasma activities in the babies born to preeclamptic pregnancies in this study parallels the observation of reduced erythrocyte GPx 12 and suggests that, as with the maternal samples, these babies may potentially have reduced antioxidant status.
Small size at birth has been postulated to increase the risks of cardiovascular disease in later life 24 . Maternal plasma GPx activity clearly differed by pregnancy outcome, in terms both of the presence or absence of preeclampsia, and whether the birthweight centile was above or below 50% (Figure 3) . The higher plasma GPx in smaller babies was unexpected, but might reflect an adaptive response in these intrauterine growth restricted babies to try and protect these fetuses from oxidative stress. To our knowledge, this is a novel observation. This is the first study to show the presence of three of the main forms of GPx in the human placenta. Wang & Walsh, who did not differentiate the different GPxs, used Northern analysis and reported a significant decrease in expression in preeclampsia 32 . Whereas our realtime PCR analysis and found no significant differences in any of the GPxs. The immunohistochemical staining of all three GPx antibodies confirmed that as with the activities, the expression levels were significantly lower in the preeclamptic compared to normal placentae (Figure 4) . GPx in the cytotrophoblast cells is ideally located for the transportation of these GPxs into both the maternal and fetal circulations; these cells are exposed to relatively high oxygen concentrations and thus the GPxs may also protect the cells from oxidative stress 33 . Due to the role of Hofbauer cells in vasculogenesis and angiogenesis, the GPxs may play essential roles in antioxidant protection throughout placental development and may indeed be the first line of antioxidant defence as these Hofbauer cells are found from week 4 of pregnancy until term 34 .
Total placental GPx activities were also significantly lower in the preeclamptic placenta compared to normal pregnancy placentae, confirming previous studies 13, 14 . This result therefore supports the hypothesis that in the placental compartment, at least, there is decreased GPx expression and activity contributing to the oxidative stress and enhanced biological oxidation in these tissues during preeclampsia. The fact that no differences were found in placental GPx mRNA expression levels between pregnancy groups but the GPx activity was reduced in the preeclamptic placentae indicates a possible post-translational modification/mutation reducing the GPx antioxidant activity; this has been observed outside pregnancy 35 . Moreover, the negative association seen between mean placental GPx activities and maternal TBARS concentrations (Figure 2 ) in preeclampsia provides a further indication that the reduced placental antioxidant defence in the placenta could have functional effects.
The GPxs are selenoproteins, but direct associations between the selenium concentrations and
GPx activities have not previously been investigated with respect to preeclampsia. The significant positive relationships seen in pregnancy per se (Figure 1a and b) suggest that at lower maternal selenium concentrations, there is a reduction in GPx; however as the selenium concentrations increases, the placental GPx activity begins to rise rapidly. This is in line with the reports that the maternal Se concentrations must be clearly deficient to have a detrimental affect on GPx activities 36 and this appears to be the case in some of the women suffering from preeclampsia in this study. A possible hypothesis could be that the selenium concentrations may be below a threshold value for optimum GPx synthesis; this has been observed in studies of selenium deficiency in mice 37 .
Discriminant functional analysis using only maternal biochemical measurements (serum selenium concentrations and plasma GPx activities) classified 82% of the subjects into the correct pregnancy outcomes. Caution must be exercised; this study was performed at the time of delivery, when the disease was established. Longitudinal studies are needed to determine whether similar differences antedate the onset of clinically-detectable disease, that is, whether they are cause or effect. If they do occur early, they would provide a novel addition to the analytes currently suggested as predictive.
Perspectives
These data are from this cross-sectional group of women with well characterised moderate-tosevere preeclampsia. The study illustrates how trace quantities of selenium can have very significant physiological effects. There is currently considerable interest in the role of dietary selenium supplementation as prophylaxis for various forms of cancer, such as prostate cancer 38 , another condition of aberrant vascular development. If selenium deficiency is confirmed in women suffering from preeclampsia, and continues to be linked with GPx inadequacy, consideration could be given to a randomised controlled trial of selenium supplementation in pregnancy. Furthermore, as assay methods become more readily available, measurements of serum selenium and GPx activity might contribute to the early identification of women at high risk of developing the disease. Further longitudinal studies are required to elucidate a 'cause or effect' relationship for these factors. Table Legends   Table 1 . Primers, sequences, product sizes and BLAST sequence numbers for the different glutathione peroxidases measured in this study. Table 2 . Details of antibodies used. as normalized ratios x1000. ‡ P < 0.001 between normal and preeclamptic pregnancies. Table 6 . Constant and discriminant function coefficients for the maternal predictors 
